Keytruda Injection 100mg/4ml

Product Description

Keytruda Injection 100mg/4ml contains pembrolizumab, an immune checkpoint inhibitor used in the treatment of various advanced or metastatic cancers. It works by enhancing the body's immune response to help detect and destroy cancer cells.

Product Overview

Product Name: Keytruda Injection 100mg/4ml
Product Form: Injection
Pack Size: 4ml
Manufactured By: MSD
Used For: Multiple types of advanced or metastatic cancers
Prescription Required: Yes

How It Works

Pembrolizumab is a monoclonal antibody that targets the PD-1 receptor on immune cells. By blocking this pathway, it prevents cancer cells from hiding from the immune system. This allows the immune system to recognize and attack cancer cells more effectively, making it a key therapy in immuno-oncology.

Key Benefits

Effective in treating advanced or metastatic cancers when other therapies may not be suitable.
Can be used alone or with chemotherapy depending on the cancer type.
Helps activate the immune system to better fight cancer.
Improves survival outcomes in many cancer patients.

Indications

Keytruda is approved for the treatment of several cancers, including:

Non-Small Cell Lung Cancer (NSCLC)

Used alone or with chemotherapy for advanced or metastatic cases.

Melanoma

Used for advanced or unresectable melanoma, especially after failure of other therapies.

Head and Neck Cancer

For recurrent or metastatic squamous cell carcinoma of the head and neck.

Classical Hodgkin Lymphoma

Used in patients with relapsed or refractory disease.

Urothelial Carcinoma

For advanced bladder or urinary tract cancers.

Other Cancers

Also used for certain cases of cervical, gastric, esophageal, renal cell carcinoma, and other tumors responsive to immunotherapy.

How to Use

Keytruda is administered as an intravenous infusion by trained medical professionals.
Dosage and treatment intervals depend on the type of cancer and the patient’s overall health.
Self-administration is not possible or recommended.

Side Effects and Precautions

Common Side Effects

Fatigue
Rash
Diarrhea or colitis
Nausea
Loss of appetite
Cough
Shortness of breath

Serious Side Effects

Immune-related reactions affecting major organs, such as:
Pneumonitis
Colitis
Hepatitis
Nephritis
Endocrine disorders (thyroid, adrenal, or pituitary issues)

Severe allergic reactions
Infusion-related reactions such as fever, chills, or low blood pressure

Long-Term Side Effects

Chronic inflammation in organs due to persistent immune activation.

Precautions

Patients with autoimmune diseases or organ transplants must consult their oncologist due to risk of severe immune reactions.
Not recommended during pregnancy; may harm the fetus. Effective contraception is required during treatment and for 4 months after the last dose.
Not recommended during breastfeeding.
Regular liver and kidney function monitoring is essential.
May increase the risk of infections in patients with weakened immune systems.

Who Should Use

Patients diagnosed with cancers that are known to respond to pembrolizumab, under oncologist supervision.

Storage Instructions

Store according to hospital and pharmacy guidelines.
Protect from light and keep out of reach of children.

Disclaimer

This medication must be administered under oncology supervision. The information provided does not replace medical advice. Always consult your oncologist for diagnosis, treatment planning, and correct dosing instructions.